SOFIA (Bulgaria), December 2 (SeeNews) – Bulgarian blue-chip drug maker Sopharma said it has become a 51% shareholder in Latvian pharmaceutical company Briz after it emerged the deal needed no anti-trust clearance in the home country of the acquisition target.